Home

Stina Singel, Officer, EVP HEAD OF CLINICAL DEVELOPMENT CMO ONCOLOGY: Ascendis Pharma A/S ASND Planned sale · Filed 25/02/21

Trade details

Type
Planned sale notice
Planned sale date
25/02/20
Filed
25/02/21

More to sell after $273.6K in 3 months

Ascendis Pharma A/S trades, last 26 weeks

What else happened in Ascendis Pharma A/S around then

Filed or reported within 30 days of the trade day · 25/01/21~25/03/22

Stina Singel's recent trades

  • Stina Singel

    Planned saleAscendis Pharma A/S

    $907.7K

    Filed 03/09

  • Stina Singel

    Planned saleAscendis Pharma A/S

    $45.7K

    Filed 25/12/01

  • Stina Singel

    Planned sale10b5-1 planAscendis Pharma A/S

    $2M

    Filed 25/03/04